Detalhe da pesquisa
1.
Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step?
Am J Physiol Endocrinol Metab
; 326(6): E767-E775, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38506752
2.
The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5.
Kidney Int
; 103(6): 1056-1062, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750145
3.
Soluble Urokinase Receptor and Acute Kidney Injury.
N Engl J Med
; 382(5): 416-426, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31995687
4.
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure.
J Card Fail
; 29(2): 158-167, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36122818
5.
Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease.
Nephrol Dial Transplant
; 35(3): 465-470, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30124995
6.
Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol
; 30(7): 1305-1313, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171572
7.
Runx2 is required for postnatal intervertebral disc tissue growth and development.
J Cell Physiol
; 234(5): 6679-6687, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341902
8.
MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome.
Pediatr Res
; 85(4): 477-483, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659270
9.
Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.
Am J Physiol Renal Physiol
; 314(3): F471-F482, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29167172
10.
Soluble Urokinase Receptor and Chronic Kidney Disease.
N Engl J Med
; 373(20): 1916-25, 2015 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26539835
11.
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.
BMC Nephrol
; 19(1): 361, 2018 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30558559
12.
Targeting mTOR Signaling Can Prevent the Progression of FSGS.
J Am Soc Nephrol
; 28(7): 2144-2157, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270414
13.
BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization.
J Pathol
; 235(5): 731-44, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25408545
14.
A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules.
J Am Soc Nephrol
; 26(11): 2741-52, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25858967
15.
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.
J Am Soc Nephrol
; 26(6): 1443-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25573908
16.
Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
J Am Soc Nephrol
; 26(1): 133-47, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24925721
17.
Reduction of proteinuria through podocyte alkalinization.
J Biol Chem
; 289(25): 17454-67, 2014 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24817115
18.
Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
Pediatr Nephrol
; 30(3): 469-77, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25239302
19.
Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.
BMC Nephrol
; 16: 111, 2015 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26198842
20.
All-electron relativistic multireference configuration interaction investigation of fluoroiodo carbene.
J Phys Chem A
; 118(13): 2447-52, 2014 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24611930